FCGR3A and rheumatoid arthritis: Ruyssen-Witrand et al. [98] evaluated the association between single nucleotide polymorphisms in the FCGR3A gene and response to RTX treatment in 111 patients with RA who did not respond to or tolerate anti-TNF therapy.